대한수혈학회지 (The Korean Journal of Blood Transfusion)

  • 제29권3호
  • /
  • Pages.253-261
  • /
  • 2018
  • /
  • 1226-9336(pISSN)
  • /
  • 2383-6881(eISSN)
대한수혈학회 (The Korean Society of Blood Transfusion)
권호 표지
DOI QR코드

DOI QR Code

일개 3차 의료기관의 대량수혈 혈액 사용 분석

Analysis of Massive Transfusion Blood Product Use in a Tertiary Care Hospital

  • 임영애 (아주대학교 의과대학 진단검사의학교실) ;
  • 정경원 (아주대학교병원 외상센터) ;
  • 이국종 (아주대학교병원 외상센터)
  • 투고 : 2018.10.12
  • 심사 : 2018.12.03
  • 발행 : 2018.12.31
⟨ 이전 논문 다음 논문 ⟩

초록

배경: 대량수혈은 혈액은행의 상당한 집중을 요하게 된다. 이 연구의 목적은 아주대병원의 대량 수혈에 사용된 혈액제제와 외상센터에서 응급환자들을 위하여 직접 사용되었던 O형 Rh 양성농축적혈구를(이하 O형 혈액) 분석하고자 하였다. 방법: 대량수혈은 24시간 이내 10 단위 이상의 적혈구제제를 수혈 받은 것으로 정의하였다. 수혈을 포함한 진료 기록은 병원정보시스템에서 추출하여 검토하였다. 병원정보시스템을 통하여 2016년 3월부터 2017년 11월까지 출고된 총 적혈구제제, 신선동결혈장, 혈소판제제(성분채집혈소판 혹은 농축혈소판)에 대한 정보를 검토하였다. 한 단위의 성분채집혈소판은 6 단위의 농축혈소판과 동일한 것으로 간주하였다. 결과: 345건의 대량수혈이 발생하였으며, 적혈구제제 11.7% (6233/53268), 신선동결혈장 24.3% (4717/19376), 그리고 혈소판제제 4.8% (4473/94166)가 대량수혈에 사용되었다(P<0.001). 대량수혈과 비대량수혈에 사용된 적혈구제제의 혈액형은 각각 A형 28.0%와 34.1%, B형 27.1%와 26.0%, O형 37.3%와 29.7% 그리고 AB형 7.5%와 10.2%였다(P<0.001). 적혈구제제:신선동결혈장:혈소판제제의 비율은 대량수혈은 1:0.76:0.72인 반면, 비대량수혈은 1:0.31:1.91을 나타내었다. 응급 O형 혈액은 461 단위가 대량수혈 환자의 36.2% (125/34)에서 사용되었으며, 한 환자당 사용된 응급 O형 혈액은 1~18단위까지 다양하였다. 결론: O형 적혈구는 대량수혈시 많이 이용되므로 대량수혈시 응급 O형 혈액의 남용을 최소화하기 위한 의료진들의 지속적인 교육이 필요하다. 신선동결혈장도 대량수혈시 자주 사용되므로 대량수혈시 즉시 가용할 수 있는 혈장 해동에 대한 수기를 갖추는 것이 중요할 것으로 여겨진다.

Background: A massive blood transfusion (MT) requires significant efforts by the Blood Bank. This study examined blood product use in MT and emergency O Rh Positive red cells (O RBCs) available directly for emergency patients from the Trauma Center in Ajou University Hospital. Methods: MT was defined as a transfusion of 10 or more RBCs within 24 hours. The extracted data for the total RBCs, fresh frozen plasma (FFP), platelets (PLTs, single donor platelets (SDP) and random platelet concentrates (PC)) issued from Blood Bank between March 2016 and November 2017 from Hospital Information System were reviewed. SDP was considered equivalent to 6 units of PC. Results: A total of 345 MTs, and 6233/53268 (11.7%) RBCs, 4717/19376 (24.3%) FFP, and 4473/94166 (4.8%) PLTs were used in MT (P<0.001). For the RBC products in MT and non-MT transfusions, 28.0% and 34.1% were group A; 27.1% and 26.0% were group B; 37.3% and 29.7% were group O, and 7.5% and 10.2% were group AB (P<0.001). The ratios of RBC:FFP:PLT use were 1:0.76:0.72 in MT and 1:0.31:1.91 in non-MT (P<0.001). A total of 461 O RBCs were used in 36.2% (125/345) of MT cases and the number of O RBCs transfused per patient ranged from 1 to 18. Conclusion: RBCs with the O blood group are most used for MT. Ongoing education of clinicians to minimize the overuse of emergency O RBCs in MT is required. A procedure to have thawed plasma readily available in MT appears to be of importance because FFP was used frequently in MT.

키워드

참고문헌

  1. The Korean society of hematology. Massive transfusion in hematology. 3rd ed. Seoul: Panmun Education Co. Ltd, 2018:694
  2. Kang BH, Choi D, Cho J, Kwon J, Huh Y, Moon J, et al. Efficacy of uncross-matched type O packed red blood cell transfusion to traumatic shock patients: a propensity score match study. J Korean Med Sci 2017;32:2058-63 https://doi.org/10.3346/jkms.2017.32.12.2058
  3. Selleng K, Jenichen G, Denker K, Selleng S, Mullejans B, Greinacher A. Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, singlecentre, observational study. Lancet Haematol 2017;4:e218-24 https://doi.org/10.1016/S2352-3026(17)30051-0
  4. Ministry of Health and Welfare Korean Center of Disease Control (KCDC). Standard operation manual for emergency and massive transfusion at hospitals. 1st ed. Cheongju: KCDC, 2018:6
  5. Han KS, Park KU, Song EY. Transfusion medicine. 4th ed. Seoul: Korea medical Book Publisher, 2014:205
  6. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001;41:56-60 https://doi.org/10.1046/j.1537-2995.2001.41010056.x
  7. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008;6:62-9
  8. Dentali F, Sironi AP, Ageno W, Turato S, Bonfanti C, Frattini F, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012;38:535-48 https://doi.org/10.1055/s-0032-1315758
  9. Arulselvi S, Rangarajan K, Sunita S, Misra MC. Blood transfusion practices at a level one trauma centre: a one-year retrospective review. Singapore Med J 2010;51:736-40
  10. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63:805-13 https://doi.org/10.1097/TA.0b013e3181271ba3
  11. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007;62:112-9 https://doi.org/10.1097/01.ta.0000250497.08101.8b
  12. Duchesne JC, Kimonis K, Marr AB, Rennie KV, Wahl G, Wells JE, et al. Damage control resuscitation in combination with damage control laparotomy: a survival advantage. J Trauma 2010;69:46-52 https://doi.org/10.1097/TA.0b013e3181df91fa
  13. Cannon JW, Khan MA, Raja AS, Cohen MJ, Como JJ, Cotton BA, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg 2017;82:605-17 https://doi.org/10.1097/TA.0000000000001333

피인용 문헌

  1. A Simple Comment of Trauma-Induced Coagulopathy and Massive Transfusion vol.31, pp.2, 2018, https://doi.org/10.17945/kjbt.2020.31.2.101